Log in

NASDAQ:CYRXCryoPort Stock Price, Forecast & News

$23.79
-0.60 (-2.46 %)
(As of 06/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$23.58
Now: $23.79
$24.59
50-Day Range
$16.49
MA: $20.72
$26.12
52-Week Range
$12.40
Now: $23.79
$26.61
Volume443,104 shs
Average Volume526,909 shs
Market Capitalization$906.42 million
P/E RatioN/A
Dividend YieldN/A
Beta0.84
CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, cell lines, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Irvine, CA.
Read More
CryoPort logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.5Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.17 out of 5 stars


Industry, Sector and Symbol

Industry Freight transportation arrangement
Sub-IndustryN/A
Current SymbolNASDAQ:CYRX
CUSIPN/A
Phone949-470-2300

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$33.94 million
Book Value$3.52 per share

Profitability

Net Income$-18,330,000.00

Miscellaneous

EmployeesN/A
Market Cap$906.42 million
Next Earnings Date8/13/2020 (Estimated)
OptionableOptionable

Receive CYRX News and Ratings via Email

Sign-up to receive the latest news and ratings for CYRX and its competitors with MarketBeat's FREE daily newsletter.

CryoPort (NASDAQ:CYRX) Frequently Asked Questions

How has CryoPort's stock been impacted by COVID-19 (Coronavirus)?

CryoPort's stock was trading at $16.62 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, CYRX shares have increased by 43.1% and is now trading at $23.79. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of CryoPort?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CryoPort in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for CryoPort.

When is CryoPort's next earnings date?

CryoPort is scheduled to release its next quarterly earnings announcement on Thursday, August 13th 2020. View our earnings forecast for CryoPort.

How were CryoPort's earnings last quarter?

CryoPort Inc (NASDAQ:CYRX) posted its quarterly earnings data on Thursday, May, 7th. The consumer goods maker reported ($0.11) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.05) by $0.06. The consumer goods maker earned $9.80 million during the quarter, compared to the consensus estimate of $9.76 million. CryoPort had a negative return on equity of 16.83% and a negative net margin of 53.66%. The company's revenue for the quarter was up 48.5% compared to the same quarter last year. During the same period in the prior year, the business posted ($0.08) EPS. View CryoPort's earnings history.

What price target have analysts set for CYRX?

5 equities research analysts have issued 1-year price targets for CryoPort's stock. Their forecasts range from $21.00 to $30.00. On average, they anticipate CryoPort's share price to reach $24.67 in the next twelve months. This suggests a possible upside of 3.7% from the stock's current price. View analysts' price targets for CryoPort.

Has CryoPort been receiving favorable news coverage?

News coverage about CYRX stock has trended very negative recently, InfoTrie Sentiment reports. The research firm rates the sentiment of media coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. CryoPort earned a news sentiment score of -3.0 on InfoTrie's scale. They also assigned news coverage about the consumer goods maker a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View the latest news aboutCryoPort.

Who are some of CryoPort's key competitors?

What other stocks do shareholders of CryoPort own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CryoPort investors own include Gilead Sciences (GILD), Advanced Micro Devices (AMD), Micron Technology (MU), Taiwan Semiconductor Mfg. (TSM), NVIDIA (NVDA), Amarin (AMRN), Crispr Therapeutics (CRSP), QUALCOMM (QCOM), Verizon Communications (VZ) and Zynga (ZNGA).

Who are CryoPort's key executives?

CryoPort's management team includes the following people:
  • Jerrell W. Shelton, Chairman, President & Chief Executive Officer
  • Phil Wilson, SVP-Global Operations & Supply Chain
  • Robert S. Stefanovich, Chief Financial Officer, Secretary & Treasurer
  • Bret Bollinger, Chief Technology Officer
  • Mark W. Sawicki, Chief Commercial Officer

What is CryoPort's stock symbol?

CryoPort trades on the NASDAQ under the ticker symbol "CYRX."

Who are CryoPort's major shareholders?

CryoPort's stock is owned by many different institutional and retail investors. Top institutional shareholders include Fred Alger Management LLC (12.40%), BlackRock Inc. (6.54%), Victory Capital Management Inc. (5.94%), Victory Capital Management Inc. (5.94%), Redmile Group LLC (4.77%) and TimesSquare Capital Management LLC (3.83%). Company insiders that own CryoPort stock include Jerrell Shelton, Richard J Berman and Robert Stefanovich. View institutional ownership trends for CryoPort.

Which major investors are selling CryoPort stock?

CYRX stock was sold by a variety of institutional investors in the last quarter, including Silvercrest Asset Management Group LLC, Precept Management LLC, Victory Capital Management Inc., Victory Capital Management Inc., BlackRock Inc., TimesSquare Capital Management LLC, D.A. Davidson & CO., and Columbus Circle Investors. Company insiders that have sold CryoPort company stock in the last year include Richard J Berman, and Robert Stefanovich. View insider buying and selling activity for CryoPort.

Which major investors are buying CryoPort stock?

CYRX stock was bought by a variety of institutional investors in the last quarter, including Redmile Group LLC, Janus Henderson Group PLC, GW&K Investment Management LLC, Federated Hermes Inc., Aviva PLC, Invesco Ltd., Wellington Management Group LLP, and Genesee Capital Advisors LLC. View insider buying and selling activity for CryoPort.

How do I buy shares of CryoPort?

Shares of CYRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is CryoPort's stock price today?

One share of CYRX stock can currently be purchased for approximately $23.79.

How big of a company is CryoPort?

CryoPort has a market capitalization of $906.42 million and generates $33.94 million in revenue each year. The consumer goods maker earns $-18,330,000.00 in net income (profit) each year or ($0.55) on an earnings per share basis.

What is CryoPort's official website?

The official website for CryoPort is www.cryoport.com.

How can I contact CryoPort?

CryoPort's mailing address is 112 Westwood Place Suite 350, Brentwood TN, 37027. The consumer goods maker can be reached via phone at 949-470-2300 or via email at [email protected]

This page was last updated on 6/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.